With the agreement, Creo aims to make devices compatible with Intuitive’s robotic technology, Creo said in a May 23 news release emailed to Becker’s. The deal also provides a framework for joint clinical studies between the companies.
“Technological advancements are facilitating a paradigm shift in the way many surgical procedures are delivered, and we look forward to working together to enable additional options for patients using this combined state-of-the-art technology,” Creo CEO Craig Gulliford said in the release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.